NCT04507568

Brief Summary

This is a single center, prospective, investigator initiated, randomized controlled study of patients with breast cancer who will be receiving radiation therapy as per SOC. Patients will be randomized in either the person-centered model-of-care versus the standard model of care. Patients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to RT SOC procedures. Patients randomized to the standard model of care will be treated as per SOC. Questionnaires will be administered to both arms at baseline, and at the first and last day of treatment. In addition to the main study, patients will have the option to participate in a semi-structured one on one interview upon completion of their radiotherapy course.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
15mo left

Started Aug 2020

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Aug 2020Aug 2027

First Submitted

Initial submission to the registry

July 29, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 11, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

August 13, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2022

Completed
5.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Expected
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

July 29, 2020

Last Update Submit

March 3, 2026

Conditions

Keywords

Radiation TherapyPatient ExperienceAnxiety Levels

Outcome Measures

Primary Outcomes (1)

  • Patient Anxiety Levels

    Hospital Anxiety and Depression Scale (HADS) questionnaire

    Up to 5 weeks.

Secondary Outcomes (5)

  • Patient-reported self-efficacy

    Up to 5 weeks.

  • Patient-reported engagement level

    Up to 5 weeks.

  • Patient-reported experience

    Up to 5 weeks.

  • Patient-reported experience

    Up to 5 weeks.

  • Patient-reported preparedness for radiation therapy

    Up to 5 weeks.

Study Arms (2)

Person-Centered Model-of-Care

EXPERIMENTAL

Patients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to the standard of care, radiation therapy procedures.

Other: Quality of Life Questionnaires

Standard Model-of-Care

OTHER

Patients randomized to the standard model of care will be treated as per standard of care.

Other: Quality of Life Questionnaires

Interventions

Quality of Life questionnaires will be administered to both arms at baseline, and at the first and last day of treatment.

Person-Centered Model-of-CareStandard Model-of-Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years or older
  • Diagnosis of non-metastatic breast cancer
  • Intended to receive radiation therapy to the breast/chest-wall and regional lymph nodes
  • Ability to communicate in English without assistance of another person
  • Ability to provide informed consent

You may not qualify if:

  • Commenced any radiation therapy-specific procedures (e.g. education, CT-simulation, etc.)
  • Received a previous course of radiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2C1, Canada

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2020

First Posted

August 11, 2020

Study Start

August 13, 2020

Primary Completion

March 24, 2022

Study Completion (Estimated)

August 1, 2027

Last Updated

March 5, 2026

Record last verified: 2026-03

Locations